Current Projects

Search for Projects
View Projects
Project Title
by Subject/Focus Area
by Board/Committee
by Major Unit
Provisional Committee Appointments Open for Formal Public Comments
by Last Update
Meeting Information
Conflict of Interest Policy
Committee Appointment Process
More Project Information and to provide FEEDBACK on the Project

 Printer Friendly Version

Meeting Information

Project Title: Ensuring Patient Access to Affordable Drug Therapies

PIN: IOM-HCS-15-01         

Major Unit:
Health and Medicine Division

Sub Unit:
Board on Health Care Services

Madhavan, Guru

Subject/Focus Area:
Health and Medicine; Policy for Science and Technology

Ensuring Patient Access to Affordable Drug Therapies, Meeting II and Public Workshop
December 13, 2016 - December 14, 2016
The Liaison Capitol Hill,
415 New Jersey Avenue NW,
Washington DC, DC 20001

If you would like to attend the sessions of this meeting that are open
to the public or need more information please contact:

Contact Name: Francis Amankwah
Phone: 2023343093



9:00 am: Welcome Remarks, Norman Augustine

9:05 am: Plenary Session I, Market and Other Dimensions of Affordable Drug Therapies
Moderator: Peter Sands
Steve Miller, Express Scripts
Robert Galvin, Blackstone Group
Peter Bach, Memorial Sloan Kettering Cancer Center

10:20 am: Break

10:30 am: Plenary Session II, Financial Dimensions of Affordable Drug Therapies
Moderator: Jeff Bingaman
Ron Cohen, Acorda Therapeutics and Biotechnology Industry Organization
Harold Paz, Aetna
Andrew Lo, MIT Sloan School of Management (by phone)

11:45 am: Plenary Session III, Perspectives on R&D Innovation and Affordability
Christopher Viehbacher, Boston Pharmaceuticals; Formerly, Sanofi

12:30 pm: Lunch (on your own)

1:30 pm: Breakout Session A, Structural Factors and Innovation
Moderator: Stacie Dusetzina
Susan Stuard, Oregon Health Sciences University
Mason Tenaglia, QuintilesIMS Institute
Bruce Rector, Doctors for America
Kevin Schulman, Duke University School of Medicine

Breakout Session B, Analytical, Regulatory, and Pricing Factors
Moderator: Michelle Mello
Jeremy Greene, Johns Hopkins School of Medicine
Steven Pearson, Institute for Clinical and Economic Review
Joseph DiMasi, Tufts Center for the Study of Drug Development
Haime Workie, Financial Industry Regulatory Authority

3:00 pm: Break

3:15 pm: Plenary Session IV, Consumers’ Perspectives on Affordable Medications
Moderator: Martha Gaines
Stacie Maass, American Pharmacists Association
Gwen Darien, National Patient Advocate Foundation
David Schleifer, Public Agenda
John Rother, National Coalition on Health Care

4:45 pm: Public Comment
Moderator: Norman Augustine

5:30 pm: Adjournment

Closed Session Summary Posted After the Meeting

The following committee members were present at the closed sessions of the meeting:
Norman Augustine (Chair)
Jeff Bingaman
Rena Conti
Kay Dickersin
Stacie Dusetzina
Martha Gaines
Rebekah Gee
Victoria Hale
Michelle Mello
Eliseo Pérez-Stable
Charles Phelps
Diane Rowland
Vinod Sahney
Peter Sands
Henri Termeer

The following topics were discussed in the closed sessions:
Bias and Conflict of Interest Discussion.
Scope of study and committee’s work plan; topical research needs.
Discussion of public workshop presentations.
Planning for next committee meeting in January, 2017.

The following materials (written documents) were made available to the committee in the closed sessions:
Draft report outline
Extracts from Public session PowerPoint presentations

Date of posting of Closed Session Summary: December 15, 2016